Related Experiment Video
Updated: Jan 9, 2026

A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
Deciphering the liver's role in pancreatic cancer metastasis: pathways and therapeutic approaches
Jose Inzunza1, Andrea C Del Valle2,3,4
1Department of Laboratory Medicine, Karolinska Institutet, Huddinge, Sweden. jose.inzunza@ki.se.
Abstract:
The liver frequently serves as a site for metastasis in pancreatic ductal adenocarcinoma (PDAC), attributable to its extensive blood supply and supportive microenvironment, which fosters the formation of a pre-metastatic niche that facilitates tumor dissemination. Deciphering the mechanisms underlying niche formation has historically been challenging, requiring detailed investigation into the interactions between primary tumors and metastatic sites. Although these interactions were previously poorly understood, recent advances have elucidated key pathways involved in this process. These insights have been enabled by cutting-edge techniques, including spatial histological mapping, single-cell sequencing, and the identification of novel molecular markers in pancreatic and hepatic metastases. Furthermore, this review revisits and critically evaluates Paget's 'seed and soil' hypothesis in light of current evidence from studies on liver metastatic niches. This review aims to deepen our understanding of liver metastasis in PDAC, with potential implications for the development of targeted therapies and improved clinical outcomes.
Related Concept Videos
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Targeted Cancer Therapies
There are several types of targeted therapies against...

